{"entity":{"type":"insider","cik":"0001725663","url":"/insider/0001725663","json_url":"/insider/0001725663.json","name":"WENTWORTH KORY JAMES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":31,"first":"2018-12-21","last":"2026-04-02","span_basis":"filed_date"},"name_variants":[{"name":"WENTWORTH KORY JAMES","source":"filing","n_filings":31,"first_seen":"2018-12-21","last_seen":"2026-04-02"}],"transactions":[{"id":6025715,"accession":"0001725663-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725663-26-000005","line_url":"/filing/0001725663-26-000005#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":12.95,"price_display":"12.95","price_state":"stated","total_value":32375.0,"total_display":"32,375.00","shares_owned_after":119010.0,"shares_owned_after_display":"119,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":6025712,"accession":"0001725663-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001725663-26-000003","line_url":"/filing/0001725663-26-000003#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11388.0,"shares_display":"11,388","price_per_share":13.0151,"price_display":"13.02","price_state":"stated","total_value":148215.9588,"total_display":"148,215.96","shares_owned_after":121510.0,"shares_owned_after_display":"121,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":6025709,"accession":"0001725663-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725663-26-000003","line_url":"/filing/0001725663-26-000003#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5089.0,"shares_display":"5,089","price_per_share":13.0011,"price_display":"13.00","price_state":"stated","total_value":66162.5979,"total_display":"66,162.60","shares_owned_after":132898.0,"shares_owned_after_display":"132,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":5778936,"accession":"0001725663-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725663-26-000002","line_url":"/filing/0001725663-26-000002#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7988.0,"shares_display":"7,988","price_per_share":12.2549,"price_display":"12.25","price_state":"stated","total_value":97892.1412,"total_display":"97,892.14","shares_owned_after":137987.0,"shares_owned_after_display":"137,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":4743550,"accession":"0001725663-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001725663-25-000004","line_url":"/filing/0001725663-25-000004#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8910.0,"shares_display":"8,910","price_per_share":9.9811,"price_display":"9.98","price_state":"stated","total_value":88931.601,"total_display":"88,931.60","shares_owned_after":110026.0,"shares_owned_after_display":"110,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-24","scope":"insider"},{"id":4506961,"accession":"0001689375-25-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-25-000016","line_url":"/filing/0001689375-25-000016#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1784.0,"shares_display":"1,784","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":19035.28,"total_display":"19,035.28","shares_owned_after":109536.0,"shares_owned_after_display":"109,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":3007305,"accession":"0001689375-24-000068","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-24-000068","line_url":"/filing/0001689375-24-000068#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.9956,"price_display":"20.00","price_state":"stated","total_value":99978.0,"total_display":"99,978.00","shares_owned_after":73849.0,"shares_owned_after_display":"73,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-03","scope":"insider"},{"id":3007299,"accession":"0001689375-24-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000068","line_url":"/filing/0001689375-24-000068#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":19.9703,"price_display":"19.97","price_state":"stated","total_value":19970.3,"total_display":"19,970.30","shares_owned_after":73849.0,"shares_owned_after_display":"73,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2406396,"accession":"0001689375-24-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000065","line_url":"/filing/0001689375-24-000065#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8637.0,"shares_display":"8,637","price_per_share":19.9794,"price_display":"19.98","price_state":"stated","total_value":172562.0778,"total_display":"172,562.08","shares_owned_after":73849.0,"shares_owned_after_display":"73,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2406390,"accession":"0001689375-24-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000055","line_url":"/filing/0001689375-24-000055#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3195.0,"shares_display":"3,195","price_per_share":14.971,"price_display":"14.97","price_state":"stated","total_value":47832.345,"total_display":"47,832.34","shares_owned_after":76486.0,"shares_owned_after_display":"76,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":2615398,"accession":"0001689375-24-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000039","line_url":"/filing/0001689375-24-000039#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1758.0,"shares_display":"1,758","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":26282.1,"total_display":"26,282.10","shares_owned_after":81412.0,"shares_owned_after_display":"81,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-07-10","scope":"insider"},{"id":3226001,"accession":"0001689375-24-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000008","line_url":"/filing/0001689375-24-000008#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4086.0,"shares_display":"4,086","price_per_share":12.3067,"price_display":"12.31","price_state":"stated","total_value":50285.1762,"total_display":"50,285.18","shares_owned_after":74170.0,"shares_owned_after_display":"74,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":8344634,"accession":"0001689375-23-000077","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001689375-23-000077","line_url":"/filing/0001689375-23-000077#line-7","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":16.67,"price_display":"16.67","price_state":"stated","total_value":1566.98,"total_display":"1,566.98","shares_owned_after":49571.0,"shares_owned_after_display":"49,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-26","scope":"insider"},{"id":8344627,"accession":"0001689375-23-000077","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001689375-23-000077","line_url":"/filing/0001689375-23-000077#line-5","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6529.0,"shares_display":"6,529","price_per_share":15.2417,"price_display":"15.24","price_state":"stated","total_value":99513.0593,"total_display":"99,513.06","shares_owned_after":53248.0,"shares_owned_after_display":"53,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-26","scope":"insider"},{"id":8344623,"accession":"0001689375-23-000077","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000077","line_url":"/filing/0001689375-23-000077#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3677.0,"shares_display":"3,677","price_per_share":16.4837,"price_display":"16.48","price_state":"stated","total_value":60610.5649,"total_display":"60,610.56","shares_owned_after":49571.0,"shares_owned_after_display":"49,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-26","scope":"insider"},{"id":8344616,"accession":"0001689375-23-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000077","line_url":"/filing/0001689375-23-000077#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":15.0703,"price_display":"15.07","price_state":"stated","total_value":33154.66,"total_display":"33,154.66","shares_owned_after":49571.0,"shares_owned_after_display":"49,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider"},{"id":8089279,"accession":"0001689375-23-000064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000064","line_url":"/filing/0001689375-23-000064#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":904.0,"shares_display":"904","price_per_share":13.4522,"price_display":"13.45","price_state":"stated","total_value":12160.7888,"total_display":"12,160.79","shares_owned_after":49617.0,"shares_owned_after_display":"49,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider"},{"id":8089277,"accession":"0001689375-23-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-23-000064","line_url":"/filing/0001689375-23-000064#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46.0,"shares_display":"46","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":645.38,"total_display":"645.38","shares_owned_after":49571.0,"shares_owned_after_display":"49,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider"},{"id":8048912,"accession":"0001689375-23-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000048","line_url":"/filing/0001689375-23-000048#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3884.0,"shares_display":"3,884","price_per_share":17.9979,"price_display":"18.00","price_state":"stated","total_value":69903.8436,"total_display":"69,903.84","shares_owned_after":36747.0,"shares_owned_after_display":"36,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":8048905,"accession":"0001689375-23-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000048","line_url":"/filing/0001689375-23-000048#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6116.0,"shares_display":"6,116","price_per_share":17.9788,"price_display":"17.98","price_state":"stated","total_value":109958.3408,"total_display":"109,958.34","shares_owned_after":36747.0,"shares_owned_after_display":"36,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8594279,"accession":"0001689375-23-000044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-23-000044","line_url":"/filing/0001689375-23-000044#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8907.0,"shares_display":"8,907","price_per_share":15.1711,"price_display":"15.17","price_state":"stated","total_value":135128.9877,"total_display":"135,128.99","shares_owned_after":27957.0,"shares_owned_after_display":"27,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":8594277,"accession":"0001689375-23-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000044","line_url":"/filing/0001689375-23-000044#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8593.0,"shares_display":"8,593","price_per_share":14.8399,"price_display":"14.84","price_state":"stated","total_value":127519.2607,"total_display":"127,519.26","shares_owned_after":36864.0,"shares_owned_after_display":"36,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":8662400,"accession":"0001689375-23-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000015","line_url":"/filing/0001689375-23-000015#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1602.0,"shares_display":"1,602","price_per_share":10.4625,"price_display":"10.46","price_state":"stated","total_value":16760.925,"total_display":"16,760.92","shares_owned_after":42302.0,"shares_owned_after_display":"42,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":8662394,"accession":"0001689375-23-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-23-000015","line_url":"/filing/0001689375-23-000015#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145.0,"shares_display":"145","price_per_share":11.2282,"price_display":"11.23","price_state":"stated","total_value":1628.089,"total_display":"1,628.09","shares_owned_after":42157.0,"shares_owned_after_display":"42,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":6688748,"accession":"0001689375-22-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000049","line_url":"/filing/0001689375-22-000049#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4550.0,"shares_display":"4,550","price_per_share":18.9534,"price_display":"18.95","price_state":"stated","total_value":86237.97,"total_display":"86,237.97","shares_owned_after":16509.0,"shares_owned_after_display":"16,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-12","scope":"insider"},{"id":6793507,"accession":"0001689375-22-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000048","line_url":"/filing/0001689375-22-000048#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":3610.0,"total_display":"3,610.00","shares_owned_after":16509.0,"shares_owned_after_display":"16,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-06","scope":"insider"},{"id":6793498,"accession":"0001689375-22-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000048","line_url":"/filing/0001689375-22-000048#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2910.0,"shares_display":"2,910","price_per_share":18.1957,"price_display":"18.20","price_state":"stated","total_value":52949.487,"total_display":"52,949.49","shares_owned_after":16509.0,"shares_owned_after_display":"16,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6104586,"accession":"0001689375-22-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000046","line_url":"/filing/0001689375-22-000046#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.1,"price_display":"18.10","price_state":"stated","total_value":3620.0,"total_display":"3,620.00","shares_owned_after":16509.0,"shares_owned_after_display":"16,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6358669,"accession":"0001104659-22-095126","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-095126","line_url":"/filing/0001104659-22-095126#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1551.0,"shares_display":"1,551","price_per_share":14.1754,"price_display":"14.18","price_state":"stated","total_value":21986.0454,"total_display":"21,986.05","shares_owned_after":10986.0,"shares_owned_after_display":"10,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-26","scope":"insider"},{"id":6358666,"accession":"0001104659-22-095126","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-095126","line_url":"/filing/0001104659-22-095126#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2817.0,"shares_display":"2,817","price_per_share":13.5226,"price_display":"13.52","price_state":"stated","total_value":38093.1642,"total_display":"38,093.16","shares_owned_after":12838.0,"shares_owned_after_display":"12,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6358663,"accession":"0001104659-22-095126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-095126","line_url":"/filing/0001104659-22-095126#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":301.0,"shares_display":"301","price_per_share":14.227,"price_display":"14.23","price_state":"stated","total_value":4282.327,"total_display":"4,282.33","shares_owned_after":12537.0,"shares_owned_after_display":"12,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6575582,"accession":"0001104659-22-093784","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-22-093784","line_url":"/filing/0001104659-22-093784#line-6","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2909.0,"shares_display":"2,909","price_per_share":13.0903,"price_display":"13.09","price_state":"stated","total_value":38079.6827,"total_display":"38,079.68","shares_owned_after":14538.0,"shares_owned_after_display":"14,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-23","scope":"insider"},{"id":6575576,"accession":"0001104659-22-093784","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-093784","line_url":"/filing/0001104659-22-093784#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217.0,"shares_display":"217","price_per_share":13.0047,"price_display":"13.00","price_state":"stated","total_value":2822.0199,"total_display":"2,822.02","shares_owned_after":16044.0,"shares_owned_after_display":"16,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-23","scope":"insider"},{"id":6575572,"accession":"0001104659-22-093784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-093784","line_url":"/filing/0001104659-22-093784#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8529.0,"shares_display":"8,529","price_per_share":13.0766,"price_display":"13.08","price_state":"stated","total_value":111530.3214,"total_display":"111,530.32","shares_owned_after":16144.0,"shares_owned_after_display":"16,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider"},{"id":6214848,"accession":"0001104659-22-092658","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-22-092658","line_url":"/filing/0001104659-22-092658#line-6","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2600.0,"total_display":"2,600.00","shares_owned_after":20221.0,"shares_owned_after_display":"20,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-18","scope":"insider"},{"id":6214840,"accession":"0001104659-22-092658","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-092658","line_url":"/filing/0001104659-22-092658#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":13.07,"price_display":"13.07","price_state":"stated","total_value":2614.0,"total_display":"2,614.00","shares_owned_after":20341.0,"shares_owned_after_display":"20,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-18","scope":"insider"},{"id":6214830,"accession":"0001104659-22-092658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-092658","line_url":"/filing/0001104659-22-092658#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2600.0,"total_display":"2,600.00","shares_owned_after":20441.0,"shares_owned_after_display":"20,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":2530691,"accession":"0001562180-20-005317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-005317","line_url":"/filing/0001562180-20-005317#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":61.0,"price_display":"61.00","price_state":"stated","total_value":5002.0,"total_display":"5,002.00","shares_owned_after":9512.0,"shares_owned_after_display":"9,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2405759,"accession":"0001562180-20-005203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-005203","line_url":"/filing/0001562180-20-005203#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":596.0,"shares_display":"596","price_per_share":66.38,"price_display":"66.38","price_state":"stated","total_value":39562.48,"total_display":"39,562.48","shares_owned_after":9594.0,"shares_owned_after_display":"9,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":3105080,"accession":"0001562180-20-004310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004310","line_url":"/filing/0001562180-20-004310#line-2","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":65.0065,"price_display":"65.01","price_state":"stated","total_value":5980.598,"total_display":"5,980.60","shares_owned_after":10252.0,"shares_owned_after_display":"10,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":3105077,"accession":"0001562180-20-004310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-004310","line_url":"/filing/0001562180-20-004310#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62.0,"shares_display":"62","price_per_share":65.5616,"price_display":"65.56","price_state":"stated","total_value":4064.8192,"total_display":"4,064.82","shares_owned_after":10190.0,"shares_owned_after_display":"10,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":2946118,"accession":"0001562180-20-000311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-000311","line_url":"/filing/0001562180-20-000311#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":89.9712,"price_display":"89.97","price_state":"stated","total_value":20063.5776,"total_display":"20,063.58","shares_owned_after":6308.0,"shares_owned_after_display":"6,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-09","scope":"insider"},{"id":8042195,"accession":"0001562180-19-006254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-006254","line_url":"/filing/0001562180-19-006254#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":397.0,"shares_display":"397","price_per_share":92.59,"price_display":"92.59","price_state":"stated","total_value":36758.23,"total_display":"36,758.23","shares_owned_after":6449.0,"shares_owned_after_display":"6,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-23","scope":"insider"},{"id":8239197,"accession":"0001209191-19-035523","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-035523","line_url":"/filing/0001209191-19-035523#line-4","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27.0,"shares_display":"27","price_per_share":126.1135,"price_display":"126.11","price_state":"stated","total_value":3405.0645,"total_display":"3,405.06","shares_owned_after":6880.0,"shares_owned_after_display":"6,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider"},{"id":8239194,"accession":"0001209191-19-035523","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-035523","line_url":"/filing/0001209191-19-035523#line-3","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17.0,"shares_display":"17","price_per_share":127.2524,"price_display":"127.25","price_state":"stated","total_value":2163.2908,"total_display":"2,163.29","shares_owned_after":6863.0,"shares_owned_after_display":"6,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider"},{"id":8239190,"accession":"0001209191-19-035523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-035523","line_url":"/filing/0001209191-19-035523#line-2","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9.0,"shares_display":"9","price_per_share":131.0456,"price_display":"131.05","price_state":"stated","total_value":1179.4104,"total_display":"1,179.41","shares_owned_after":6846.0,"shares_owned_after_display":"6,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider"},{"id":8239186,"accession":"0001209191-19-035523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-035523","line_url":"/filing/0001209191-19-035523#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":129.5113,"price_display":"129.51","price_state":"stated","total_value":1036.0904,"total_display":"1,036.09","shares_owned_after":6855.0,"shares_owned_after_display":"6,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider"},{"id":8597455,"accession":"0001209191-19-015649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015649","line_url":"/filing/0001209191-19-015649#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51.0,"shares_display":"51","price_per_share":151.71,"price_display":"151.71","price_state":"stated","total_value":7737.21,"total_display":"7,737.21","shares_owned_after":6695.0,"shares_owned_after_display":"6,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":8485910,"accession":"0001209191-19-014100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-014100","line_url":"/filing/0001209191-19-014100#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208.0,"shares_display":"208","price_per_share":150.0038,"price_display":"150.00","price_state":"stated","total_value":31200.7904,"total_display":"31,200.79","shares_owned_after":6746.0,"shares_owned_after_display":"6,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8311333,"accession":"0001209191-19-006012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-006012","line_url":"/filing/0001209191-19-006012#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001725663","owner_name":"WENTWORTH KORY JAMES","owner_url":"/insider/0001725663","role":"Officer (Principal Accounting Officer)","officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209.0,"shares_display":"209","price_per_share":125.964,"price_display":"125.96","price_state":"stated","total_value":26326.476,"total_display":"26,326.48","shares_owned_after":4403.0,"shares_owned_after_display":"4,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-30","scope":"insider"}],"next_cursor":"2019-01-28|8311333","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Officer (Chief Financial Officer)","n_filings":21,"first_seen":"2022-08-18","last_seen":"2026-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Officer (Principal Accounting Officer)","n_filings":10,"first_seen":"2018-12-21","last_seen":"2020-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001725663","retrieved_at":"2026-08-21T17:19:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}